Gilead Sciences (GILD) Assets Average (2009 - 2026)
Gilead Sciences posted quarterly Assets Average of $57.7 billion for Q1 2026, little changed year-on-year from $57.7 billion in Q1 2025, and down 1.92% on a QoQ basis from $58.8 billion in Q4 2025.
Gilead Sciences (GILD) has 18 years of Assets Average data on file, last reported at $57.7 billion in Q1 2026.
- For the quarter ending Q1 2026, Assets Average changed 0.11% year-over-year to $57.7 billion; the trailing twelve-month figure through Mar 2026 stood at $57.7 billion (changed 0.11% YoY), and the FY2025 full-year result was $59.0 billion, down 2.56% from the prior year.
- Assets Average for Q1 2026 stood at $57.7 billion, down from $58.8 billion in the prior quarter.
- Across five years, Assets Average topped out at $65.5 billion in Q1 2022 and bottomed at $54.1 billion in Q3 2024.
- The 5-year median for Assets Average is $59.2 billion (2024), against an average of $59.7 billion.
- The widest annual swing landed in 2024, when Assets Average decreased 13.32%; it then increased 5.69% in 2025.
- A 5-year view of Assets Average shows it stood at $62.9 billion in 2022, then decreased by 0.98% to $62.2 billion in 2023, then dropped by 8.82% to $56.8 billion in 2024, then rose by 3.56% to $58.8 billion in 2025, then fell by 1.92% to $57.7 billion in 2026.
- The last three Assets Average figures came in at $57.7 billion (Q1 2026), $58.8 billion (Q4 2025), and $57.1 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 114.53 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 200.05 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 135.21 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 132.78 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 91.55 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 57.65 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 208.08 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 88.26 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | 314.07 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57.65 Bn |
| Dec 31, 2025 | 58.78 Bn |
| Sep 30, 2025 | 57.13 Bn |
| Jun 30, 2025 | 56.08 Bn |
| Mar 31, 2025 | 57.71 Bn |
| Dec 31, 2024 | 56.76 Bn |
| Sep 30, 2024 | 54.05 Bn |
| Jun 30, 2024 | 54.94 Bn |
| Mar 31, 2024 | 59.21 Bn |
| Dec 31, 2023 | 62.25 Bn |
| Sep 30, 2023 | 62.36 Bn |
| Jun 30, 2023 | 62.11 Bn |
| Mar 31, 2023 | 62.52 Bn |
| Dec 31, 2022 | 62.86 Bn |
| Sep 30, 2022 | 62.71 Bn |
| Jun 30, 2022 | 62.98 Bn |
| Mar 31, 2022 | 65.52 Bn |
| Dec 31, 2021 | 67.53 Bn |
| Sep 30, 2021 | 67.54 Bn |
| Jun 30, 2021 | 67.74 Bn |
| Mar 31, 2021 | 67.95 Bn |
| Dec 31, 2020 | 64.64 Bn |
| Sep 30, 2020 | 58.41 Bn |
| Jun 30, 2020 | 57.84 Bn |
| Mar 31, 2020 | 60.68 Bn |
| Dec 31, 2019 | 60.39 Bn |
| Sep 30, 2019 | 61.18 Bn |
| Jun 30, 2019 | 63.02 Bn |
| Mar 31, 2019 | 63.26 Bn |
| Dec 31, 2018 | 63.99 Bn |
| Sep 30, 2018 | 64.83 Bn |
| Jun 30, 2018 | 65.37 Bn |
| Mar 31, 2018 | 67.83 Bn |
| Dec 31, 2017 | 67.47 Bn |
| Sep 30, 2017 | 62.46 Bn |
| Jun 30, 2017 | 58.98 Bn |
| Mar 31, 2017 | 57.34 Bn |
| Dec 31, 2016 | 56.79 Bn |
| Sep 30, 2016 | 53.29 Bn |
| Jun 30, 2016 | 48.87 Bn |
| Mar 31, 2016 | 49.74 Bn |
| Dec 31, 2015 | 51.18 Bn |
| Sep 30, 2015 | 44.90 Bn |
| Jun 30, 2015 | 38.74 Bn |
| Mar 31, 2015 | 36.49 Bn |
| Dec 31, 2014 | 31.75 Bn |
| Sep 30, 2014 | 30.03 Bn |
| Jun 30, 2014 | 29.64 Bn |
| Mar 31, 2014 | 25.33 Bn |
| Dec 31, 2013 | 22.52 Bn |
| Sep 30, 2013 | 22.55 Bn |
| Jun 30, 2013 | 22.42 Bn |
| Mar 31, 2013 | 21.73 Bn |
| Dec 31, 2012 | 21.10 Bn |
| Sep 30, 2012 | 20.73 Bn |
| Jun 30, 2012 | 20.23 Bn |
| Mar 31, 2012 | 18.63 Bn |
| Dec 31, 2011 | 14.97 Bn |
| Sep 30, 2011 | 12.67 Bn |
| Jun 30, 2011 | 12.84 Bn |
| Mar 31, 2011 | 12.29 Bn |
| Dec 31, 2010 | 11.52 Bn |
| Mar 31, 2010 | 10.20 Bn |
| Dec 31, 2009 | 9.32 Bn |
| Sep 30, 2009 | 8.66 Bn |